Generation of the therapeutic monoclonal antibody NEO-201, derived from a cancer vaccine, which targets human malignancies and immune suppressor cells
Article in Expert Review of Vaccines (September 2024)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Article in Expert Review of Vaccines (September 2024)
Article in Kinases and Phosphatases (April 2024)
Article in International Journal of Oncology (January 2024)